STAT1 and ovarian carcinoma: HDAC4 deacetylates STAT1, thereby enhancing phosphorylation and nuclear translocation of STAT1 upon cisplatin-treatment in platinum resistant ovarian cancer cells (exposure to chemotherapy) [522].